{"id":1081995,"title":"DSEN Abstract: High potency statins and the risk of new diabetes - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-03-20","captureTimestamp":"2026-03-20T21:26:29.008000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/49225.html?wbdisable=true","snippet":"DSEN Abstract High potency statins and the risk of new diabetes This research was funded by the Drug Safety and Effectiveness Network (DSEN) and conducted by the following investigators: Colin R. Dormuth, Kristian B. Filion, J. Michael Paterson, Matthew T. James, Gary F. Teare,…","rawSnapshotUrl":"/api/snapshots/raw/1081995","browseUrl":"https://replay.healtharchive.ca/job-8/20260320212629/https://cihr-irsc.gc.ca/e/49225.html?wbdisable=true#ha_snapshot=1081995","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}